The Emerging Outcomes Demonstration / Cost Management Challenge
The current healthcare environment reshapes the three key factors in market access – value, evidence, and commercial positioning of [...]
What is the secret of the cost-efficient healthcare system in Israel, Mirel Stelian?
Israel spends only 7.6% of the GDP on healthcare – significantly less than most other Western OECD countries. At the [...]
Dutch payers are pragmatic, especially when discussing medical devices, isn’t it, Ron de Graff?
The market access process in the Netherlands can be very special, especially for medical devices. Besides standard reimbursement processes with [...]
The Belgium reimbursement pathway for digital health applications is similarly easy as in Germany, correct Katrien de Groote?
Belgium has created a similar fast-track process as in Germany even though that some differences exist. Anyway, core question with [...]
Is European market access really so difficult? Tell us the truth about being successful in Europe, Esther Nzenza!
Europe is one continent, with one Union (plus the UK)… Health policy is still the responsibility of each individual country [...]
Digital Health Care is already fully utilized in the US, isn’t it?
Dr. Stefan Walzer and Kate Claessens, the experienced consultant on healthcare in the US, are discussing the public acceptance as well as the various reimbursement pathways in [...]
Does the Italian reimbursement pathway allow for innovative drugs being highly priced, Dr. Stefano Capri and Dr. Entela Xoxi?
The Italian reimbursement system is unique in terms of its structure, especially also for innovative drugs. However, what does the new innovation pathway means to the [...]
The private health insurances as the entrance into German market access – is this true, Dr. Bastian Biermann?
The German health care system consists of the statutory and private health insurances, whereas the latter covers around 10% of [...]
How does hospital funding work in Germany, Willi Wöllner?
How does reimbursement work in the German hospital setting and how are hospitals organized doing such negotiations? What is a NUB and [...]
Prof. Dr. Juergen Wasem – What happens, when negotiations fail?
Who could be better to tell us the real insights, how the arbitration board works than Prof. Dr. Juergen Wasem, the [...]
Bibiane Schulte-Bosse – How to fight well in AMNOG negotiations.
In this Podcast episode, Dr. Stefan Walzer is explaining the details of the price negotiations within the AMNOG process together [...]
Remo Christen – Early paid access in Switzerland – Switzerland, wonderland??
In this Podcast episode, Dr. Stefan Walzer is discussing the specifics of the Swiss market access & reimbursement specifics including [...]
Preparing for a Virtual Career Fair in Health Economics & Outcomes Research (HEOR)
Do you wonder what is going on within the job market for pharmaceutical Health Economics and Outcomes Research (HEOR), and [...]
